Further evidence of Neu-1′s involvement in IR signaling is that in-vitro and in-vivo studies have concluded that insulin affects tumor progression by acting on the IR and not solely by IGF-1R cross-talk [234,235]. Here, NEU1 is linked to neoplasm.